NDC70461-0656-03: INFLUENZA VIRUS VACCINE.
The INFLUENZA VIRUS VACCINE is a the manufacturer industrial component. Key specifications include protective_storage_feature: REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS, part_name_assigned_by_controlling_agency: FLUCELVAX CELL CULTURE-BASED, TRIVALENT 2026-2027 FORMULA. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-735-0205, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| protective_storage_feature | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| part_name_assigned_by_controlling_agency | FLUCELVAX CELL CULTURE-BASED, TRIVALENT 2026-2027 FORMULA |
| NSN | 6505-01-735-0205 |
| SPECIAL FEATURES | 0.5 ML SINGLE DOSE PREFILLED SYRINGE, PG OF 10 (W/O NEEDLES) FOR FLU SEASON 2026-2027; FOR IMMUNIZING PERSONS 6 MONTHS AND OLDER; LATEX-FREE, PRESERVATIVE FREE; FOR IM ADMINISTRATION; REQUIRES REFRIGERATION BETWEEN 2-8 DEG C; DO NOT FREEEZE. DEGC |
| PROTECTIVE STORAGE FEATURE | REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEG CELSIUS |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | FLUCELVAX CELL CULTURE-BASED, TRIVALENT 2026-2027 FORMULA |